Table 2 Cox proportional hazard regression analysis on mortality of diabetic patients after first acute myocardial infarction
Characteristics (all, NÂ =Â 5344) | HR (95% CI) |
|---|---|
Sex (male vs female) | 0.98 (0.89–1.07) |
Age (65 ≤ age < 75 vs age <65) | 1.71 (1.5–1.96)*** |
Age (age ≥75 vs age <65) | 2.51 (2.2–2.85)*** |
Hypertension (yes vs no) | 1.2 (1.06–1.37)** |
Peripheral vascular disease (yes vs no) | 1.57 (1.34–1.84)*** |
Heart failure (yes vs no) | 1.35 (1.23–1.49)*** |
End stage renal disease (yes vs no) | 1.76 (1.51–2.06)*** |
Cerebrovascular disease (yes vs no) | 1.33 (1.21–1.47)*** |
Chronic obstructive pulmonary disease (yes vs no) | 1.33 (1.16–1.52)*** |
Percutaneous coronary intervention (yes vs no) | 0.54 (0.49–0.6)*** |
Any antiplatelet (yes vs no) | 0.58 (0.49–0.7)*** |
ACEI or ARB (yes vs no) | 0.72 (0.65–0.8)*** |
β-Blocker (yes vs no) | 0.79 (0.71–0.87)*** |
Heparin or low molecular weight heparin (yes vs no) | 1.02 (0.91–1.15) |
α-Glucosidase (yes vs no) | 0.95 (0.83–1.08) |
Glinides (yes vs no) | 1.05 (0.94–1.18) |
Metformin (yes vs no) | 0.77 (0.68–0.86)*** |
Sulfonylureas (yes vs no) | 0.91 (0.82–1.01) |
Thiazolidinedione (yes vs no) | 0.79 (0.59–1.04) |
DPP-4 inhibitor (yes vs no) | 0.86 (0.78–0.95)** |